PRODUCT DEVELOPMENT
RELEEV has been shown very exciting antiviral activity against the herpes virus both HSV1 and HSV2 in extensive laboratory testing conducted and published by Kenneth Thompson, Ph.D, University of Chicago and and by eminent virologist Robert Buckheit, Ph.D at Southern Research Institute in Birmingham, Alabama, and Imquest Biosciences in Frederick, Maryland.
Dr Buckheit is also Director of Infectious Diseases and Immunology at TherImmune Research Corporation.
RELEEV has been shown to soothe and heal herpes caused cold sore. Theseclinical trials were conducted at the University of New Mexico by David Riley, PhD, MD. They confirmed RELEEV Products healed cold sores first by relieving pain in 3-10 minutes then all other symptoms within 24 hours, and then healing the cold sore on average in 72 hours (3 days) and sometimes as fast as 21 hours.
The ingredients and compounds in the Products have been developed to deliver dual action: First immediate relief ofpain, then a direct action against the virus to speed healing.
The RELEEV compounds are extracts of natural ingredients. Future targets include, Epstein Barr, Chicken Pox, hepatitis and other unpleasant strains of viral infection, all the way down to the common cold. Products to treat these viral diseases are in development.